A luminous reading of the literature · Copper Tripeptide-1
GHK-Cu is a copper peptide studied for collagen, skin, hair and wound repair across five decades of research.
The glycyl-histidyl-lysine copper(II) complex stimulated fibroblast collagen synthesis from picomolar concentrations and modulates roughly a third of human genes. Every quantitative claim here is cited; every gap in the human data is left translucent rather than hidden.
What the GHK-Cu literature describes
GHK-Cu — the glycyl-L-histidyl-L-lysine copper(II) complex — stimulated collagen synthesis in human fibroblast cultures beginning between 10^-12 and 10^-11 M and peaking near 10^-9 M, an effect independent of any change in cell number [1]. That single finding, published in 1988, set the shape of everything that followed: GHK-Cu behaves as a specific metabolic signal, not a growth stimulant. The copper-bound tripeptide is endogenous, present in human plasma, saliva and urine, first isolated by Loren Pickart in 1973 as a plasma factor that coaxed aged liver tissue to synthesize proteins the way younger tissue does [6].
The molecule's reach is unusually broad. A 2018 gene-data analysis reports GHK alters expression of about 31.2% of human genes at a 50%-or-greater change threshold — 59% upregulated, 41% suppressed — with strong stimulation of the ubiquitin-proteasome system (41 genes up, 1 down) alongside DNA-repair and antioxidant gene sets [2]. In the skin, GHK-Cu stimulates synthesis of collagen, elastin, dermatan sulfate, chondroitin sulfate and the proteoglycan decorin [3]. This site gathers that record — the GHK-Cu research findings, the copper peptide hair growth research, and the GHK-Cu wound healing studies — and reads it in plain light, with the open questions kept visible.
GHK Copper Peptide: What the Research Describes
The GHK copper peptide is a single small molecule with an outsized signaling repertoire. At picomolar-to-nanomolar concentrations it directly drives dermal fibroblast synthesis of structural matrix proteins while rebalancing matrix metalloproteinases (MMP-2, MMP-9) against their TIMP inhibitors, favoring remodeling over destruction [6]. The bound copper ion is not incidental: it enables lysyl-oxidase-mediated collagen and elastin cross-linking and lends superoxide-dismutase-like antioxidant activity [3].
The GHK sequence occurs endogenously within the alpha-2(I) chain of type I collagen and in SPARC/osteonectin, so the body appears to liberate this signal during matrix turnover [1]. Plasma levels are age-dependent: GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by age 60 [3]. The downstream programs read like a tissue-repair manifest — VEGF and FGF-2 for angiogenesis, NF-kB suppression for reduced inflammation, and the Nrf2/Keap1 axis for antioxidant defense [6]. Researchers describe a pleiotropic copper chaperone rather than a single-target drug.
What Is a Copper Peptide?
A copper peptide is a short chain of amino acids bound to a copper(II) ion through multiple coordination sites — a chelate. In GHK-Cu, copper(II) coordinates to the histidine imidazole nitrogen, the glycine alpha-amino nitrogen and a deprotonated amide nitrogen, leaving the lysine side chain free; the molecular formula of the cationic complex is C14H23CuN6O4+ [6]. The chelate has a very high copper stability constant (log K of approximately 16.4), far higher than free copper salts, which limits pro-oxidant free-copper release [3].
The distinction between the peptide and its copper complex matters in the literature. The free GHK tripeptide (MW 340.38) does not reproduce MMP-2 stimulation in fibroblast cultures the way the copper complex (MW 402.92) does — copper coordination is required for most documented tissue-repair activities [6]. Because many studies use the free peptide and report systemic or gene-level effects, careful readers note which form a given paper used. That nuance runs through the rest of this digest.
Copper Tripeptide-1 (the INCI name for GHK-Cu)
Copper Tripeptide-1 is the INCI cosmetic-ingredient name for GHK-Cu — the label term that appears on skincare products containing copper-peptide actives [3]. The same molecule carries several identifiers across registries: CAS 89030-95-5, PubChem CID 71587328, FDA UNII 6BJQ43T1I9, and DrugBank DB14683. Topical Copper Tripeptide-1 is a legal cosmetic ingredient in the US, EU and UK, with a long marketed safety record [3].
That regulatory status is one half of a sharp dividing line. As a topical cosmetic ingredient, Copper Tripeptide-1 is established; as an injectable or systemic pharmaceutical, GHK-Cu has no FDA- or EMA-approved indication by any route [6]. This site reads the copper tripeptide-1 overview and the deeper mechanism together, and it keeps the cosmetic-ingredient framing distinct from the unapproved systemic one throughout.
Common questions about GHK-Cu
What is GHK-Cu and how does it work?
GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, a copper-binding tripeptide present in human plasma that acts as a copper chaperone and pleiotropic signaling molecule. It stimulates fibroblast collagen and elastin synthesis and rebalances MMPs against TIMPs at picomolar-to-nanomolar concentrations [1]. The copper ion enables matrix cross-linking and antioxidant activity [3].
What does a GHK-Cu peptide do?
In research models GHK-Cu stimulates synthesis of collagen, elastin, glycosaminoglycans and decorin, supports angiogenesis via VEGF and FGF-2, and modulates matrix metalloproteinases [6]. It behaves as a tissue-repair and matrix-remodeling signal rather than a single-pathway agonist, which is why its documented effects span skin, hair follicle, vasculature and gut epithelium [2].
What is the difference between GHK and GHK-Cu?
GHK is the free tripeptide (MW 340.38, CAS 49557-75-7); GHK-Cu is the copper(II) chelate (MW 402.92, CAS 89030-95-5). Copper coordination is required for most documented tissue-repair activities — the free peptide does not reproduce MMP-2 stimulation in fibroblast cultures [6]. The form a study uses therefore changes how its results should be read; see the difference between GHK and GHK-Cu.
What does a copper peptide do for your skin?
In dermal research GHK-Cu increases collagen production — one review reports improvement in 70% of treated subjects versus 50% for vitamin C and 40% for retinoic acid — and stimulates dermatan sulfate, chondroitin sulfate and decorin synthesis [3]. A 2025 review reproduces the 70% versus 40% procollagen comparison and frames poor skin penetration as the central delivery challenge [7].